Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-3180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Platinum and Anthracycline Therapy for Advanced Cutaneous Squamous Cell Carcinoma

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2012English

Definitive Radiotherapy for Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma of the Nose

Journal of Dermatological Research
2019English

Topical Therapy for Superficial Basal Cell Carcinoma

International Journal of Clinical & Experimental Dermatology
2017English

Medical Treatment of Advanced Cutaneous Squamous‐cell Carcinoma

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Cutaneous Side-Effects During Therapy of Melanoma by Vemurafenib

Przeglad Dermatologiczny
Dermatology
2015English

Unusual Cutaneous Langerhans Cell Sarcoma Without Extracutaneous Involvement

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Vismodegib and Orbital Excision for Treating Locally Advanced Basal Cell Carcinoma

International Medical Case Reports Journal
Medicine
2018English

Shedding Light on Photodynamic Therapy for Basal Cell Carcinoma

British Journal of Dermatology
DermatologyMedicine
2018English

Primary Cutaneous Keratinocytic Primordial Carcinoma With Triple Differentiations Into Basal Cell Carcinoma, Sqaumous Cell Carcinoma, and Porocarcinoma

Case Reports in Clinical Pathology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy